16.82
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché KROS Giù?
Forum
Previsione
Keros Therapeutics Inc Borsa (KROS) Ultime notizie
Keros Therapeutics announces final results of tender offer - MarketScreener
Keros Therapeutics (Nasdaq: KROS) completes $194M tender offer, buying 35.9% of shares - Stock Titan
Keros Therapeutics (NASDAQ:KROS) Shares Gap DownHere's Why - MarketBeat
Is Keros Therapeutics Inc. stock reversal real or fakeWeekly Investment Summary & Risk Adjusted Buy/Sell Alerts - newser.com
Keros Therapeutics reports oversubscribed $194.4 million tender offer By Investing.com - Investing.com Nigeria
Can Keros Therapeutics Inc. stock maintain operating margins2025 Technical Patterns & Fast Entry High Yield Tips - newser.com
Keros to Repurchase 11 Million Shares in Oversubscribed Tender Offer - MarketScreener
Keros Therapeutics Reports Third Quarter 2025 Financial Results - Sahm
Keros Therapeutics reports oversubscribed $194.4 million tender offer - Investing.com
Keros Therapeutics Announces Preliminary Results of Tender Offer - MarketScreener
Keros Therapeutics (Nasdaq: KROS) to Repurchase 10.95M Shares for $194.4M in Tender Offer - Stock Titan
Keros Therapeutics, Inc. (NASDAQ:KROS) Held Back By Insufficient Growth Even After Shares Climb 26% - simplywall.st
How to manage a losing position in Keros Therapeutics Inc.Portfolio Value Report & Free Accurate Trade Setup Notifications - newser.com
How to recover losses in Keros Therapeutics Inc. stockJuly 2025 Price Swings & Accurate Trade Setup Notifications - newser.com
Los Angeles Capital Management LLC Purchases New Stake in Keros Therapeutics, Inc. $KROS - MarketBeat
Is Keros Therapeutics Inc. stock attractive for income investors2025 Buyback Activity & Reliable Entry Point Alerts - newser.com
Connor Clark & Lunn Investment Management Ltd. Boosts Stake in Keros Therapeutics, Inc. $KROS - MarketBeat
Will Keros Therapeutics Inc. stock rally after Fed decisionsWeekly Profit Summary & Daily Chart Pattern Signals - newser.com
Can trapped investors hope for a rebound in Keros Therapeutics Inc.2025 Volatility Report & Safe Entry Momentum Tips - newser.com
Will Keros Therapeutics Inc. price bounce be sustainable2025 Winners & Losers & Comprehensive Market Scan Insights - newser.com
Evaluating Keros Therapeutics Inc. with trendline analysisEntry Point & Short-Term Trading Opportunity Alerts - newser.com
Can volume confirm reversal in Keros Therapeutics Inc.July 2025 Breakouts & Free Verified High Yield Trade Plans - newser.com
Will Keros Therapeutics Inc. stock return to pre crisis levelsJuly 2025 Short Interest & Weekly Top Gainers Alerts - newser.com
Keros Therapeutics' (KROS) Outperform Rating Reiterated at Oppenheimer - MarketBeat
Oppenheimer Reiterates Keros Therapeutics (KROS) Outperform Recommendation - Nasdaq
Oppenheimer Adjusts Keros Therapeutics Price Target to $27 From $23, Maintains Outperform Rating - MarketScreener
Wells Fargo & Company Lowers Keros Therapeutics (NASDAQ:KROS) Price Target to $23.00 - MarketBeat
Wells Fargo Maintains Keros Therapeutics (KROS) Overweight Recommendation - Nasdaq
KROS: Wells Fargo Lowers Price Target to $23, Maintains Overweig - GuruFocus
Keros Therapeutics Drives Nasdaq Composite Momentum In Medicine - Kalkine Media
Wall Street Analysts See a 42.78% Upside in Keros Therapeutics (KROS): Can the Stock Really Move This High? - sharewise.com
How interest rate cuts could boost Keros Therapeutics Inc. stockDay Trade & AI Enhanced Execution Alerts - newser.com
KROS vs. ARGX: Which Stock Is the Better Value Option? - sharewise.com
Why Keros Therapeutics Inc. stock remains undervaluedJuly 2025 Institutional & Accurate Technical Buy Alerts - newser.com
What is HC Wainwright's Estimate for KROS FY2025 Earnings? - MarketBeat
FY2025 EPS Estimate for Keros Therapeutics Lifted by Analyst - MarketBeat
FY2025 EPS Forecast for Keros Therapeutics Raised by Analyst - MarketBeat
Will Keros Therapeutics Inc. stock deliver consistent dividendsWeekly Profit Recap & Verified Technical Trade Signals - newser.com
Precision Trading with Keros Therapeutics Inc. (KROS) Risk Zones - news.stocktradersdaily.com
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):